ADMA ADMA BIOLOGICS INC More: the full row for ADMA BIOLOGICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,287,542 shares; 2025Q1: 2,317,542 shares; 2025Q2: 2,317,542 shares; 2025Q3: 2,412,542 shares; 2025Q4: 2,457,542 shares; 2026Q1: 3,207,542 shares; 2026Q2: 3,262,542 shares; 2026Q3: 3,262,542 shares 3,262,542 $32.7M 20.18% 0 Timeline FTH FAETH THERAPEUTICS INC More: the full row for FAETH THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 610,169 shares; 2026Q3: 610,169 shares 610,169 $18.1M 11.19% 0 Timeline PALI PALISADE BIO INC More: the full row for PALISADE BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,500,000 shares; 2026Q1: 11,414,285 shares; 2026Q2: 11,414,285 shares; 2026Q3: 11,414,285 shares 11,414,285 $15.4M 9.5% 0 Timeline NRXP NRX PHARMACEUTICALS INC More: the full row for NRX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,000,000 shares; 2026Q2: 4,091,767 shares; 2026Q3: 4,277,200 shares 4,277,200 $12.5M 7.7% +185,433 Timeline ZLAB ZAI LAB LTD More: the full row for ZAI LAB LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 400,000 shares; 2025Q1: 400,000 shares; 2025Q2: 400,000 shares; 2025Q3: 400,000 shares; 2025Q4: 400,000 shares; 2026Q1: 450,646 shares; 2026Q2: 450,646 shares; 2026Q3: 450,646 shares 450,646 $11.9M 7.32% 0 Timeline PRAX PRAXIS PRECISION MEDICINES I More: the full row for PRAXIS PRECISION MEDICINES I Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 19,000 shares; 2025Q2: 35,000 shares; 2025Q3: 31,500 shares; 2025Q4: 33,237 shares; 2026Q1: 33,237 shares; 2026Q2: 33,237 shares; 2026Q3: 33,237 shares 33,237 $9.68M 5.97% 0 Timeline SGHT SIGHT SCIENCES INC More: the full row for SIGHT SCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 629,370 shares; 2025Q1: 833,600 shares; 2025Q2: 930,000 shares; 2025Q3: 930,000 shares; 2025Q4: 920,000 shares; 2026Q1: 970,000 shares; 2026Q2: 970,000 shares; 2026Q3: 970,000 shares 970,000 $9.08M 5.6% 0 Timeline TSHA TAYSHA GENE THERAPIES INC More: the full row for TAYSHA GENE THERAPIES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 965,556 shares; 2025Q1: 1,255,556 shares; 2025Q2: 1,800,556 shares; 2025Q3: 1,800,556 shares; 2025Q4: 1,800,556 shares; 2026Q1: 1,800,556 shares; 2026Q2: 1,800,556 shares; 2026Q3: 1,800,556 shares 1,800,556 $8.77M 5.41% 0 Timeline IOVA IOVANCE BIOTHERAPEUTICS INC More: the full row for IOVANCE BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 992,000 shares; 2025Q1: 1,500,000 shares; 2025Q2: 1,500,000 shares; 2025Q3: 1,500,000 shares; 2025Q4: 1,500,000 shares; 2026Q1: 1,500,000 shares; 2026Q2: 1,500,000 shares; 2026Q3: 425,000 shares 425,000 $6.3M 3.88% -1,075,000 Timeline GPCR STRUCTURE THERAPEUTICS INC More: the full row for STRUCTURE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 90,000 shares; 2026Q1: 127,500 shares; 2026Q2: 140,000 shares; 2026Q3: 180,000 shares 180,000 $5.63M 3.47% +40,000 Timeline SYRE SPYRE THERAPEUTICS INC More: the full row for SPYRE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 50,000 shares; 2025Q1: 70,000 shares; 2025Q2: 80,000 shares; 2025Q3: 100,000 shares; 2025Q4: 100,000 shares; 2026Q1: 100,000 shares; 2026Q2: 70,000 shares; 2026Q3: 62,500 shares 62,500 $5.56M 3.43% -7,500 Timeline CLLS CELLECTIS S A More: the full row for CELLECTIS S A Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,081,501 shares; 2025Q1: 3,256,501 shares; 2025Q2: 3,256,501 shares; 2025Q3: 3,281,501 shares; 2025Q4: 3,281,501 shares; 2026Q1: 3,281,501 shares; 2026Q2: 3,281,501 shares; 2026Q3: 3,281,501 shares 3,281,501 $4.96M 3.06% 0 Timeline AURA AURA BIOSCIENCES INC More: the full row for AURA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 472,576 shares; 2025Q1: 472,576 shares; 2025Q2: 572,576 shares; 2025Q3: 572,576 shares; 2025Q4: 572,576 shares; 2026Q1: 597,576 shares; 2026Q2: 764,243 shares; 2026Q3: 764,243 shares 764,243 $4.8M 2.96% 0 Timeline DRUG BRIGHT MINDS BIOSCIENCES INC More: the full row for BRIGHT MINDS BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 67,500 shares; 2026Q2: 67,500 shares; 2026Q3: 95,000 shares 95,000 $4.73M 2.92% +27,500 Timeline ORKA ORUKA THERAPEUTICS INC More: the full row for ORUKA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 20,000 shares; 2025Q1: 58,215 shares; 2025Q2: 75,000 shares; 2025Q3: 75,000 shares; 2025Q4: 75,000 shares; 2026Q1: 75,000 shares; 2026Q2: 75,000 shares; 2026Q3: 55,000 shares 55,000 $4.58M 2.83% -20,000 Timeline ASMB ASSEMBLY BIOSCIENCES INC More: the full row for ASSEMBLY BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 50,651 shares; 2025Q1: 200,000 shares; 2025Q2: 189,350 shares; 2025Q3: 175,706 shares; 2025Q4: 175,706 shares; 2026Q1: 175,706 shares; 2026Q2: 175,706 shares; 2026Q3: 175,706 shares 175,706 $4.13M 2.55% 0 Timeline RARE ULTRAGENYX PHARMACEUTICAL IN More: the full row for ULTRAGENYX PHARMACEUTICAL IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 7,596 shares; 2025Q1: 47,500 shares; 2025Q2: 110,000 shares; 2025Q3: 135,000 shares; 2025Q4: 135,000 shares; 2026Q1: 135,000 shares; 2026Q2: 135,000 shares; 2026Q3: 135,000 shares 135,000 $2.03M 1.25% 0 Timeline FHTX FOGHORN THERAPEUTICS INC More: the full row for FOGHORN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 102,000 shares; 2026Q2: 200,000 shares; 2026Q3: 200,000 shares 200,000 $714K 0.44% 0 Timeline QTTB Q32 BIO INC More: the full row for Q32 BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 65,000 shares 65,000 $538K 0.33% new Timeline